Skip to main content

Market Overview

What Caused The Opening Gap In Altimmune?


Clinical stage immunotherapeutic biotechnology company Altimmune Inc (NYSE: ALT) today had a large opening gap of 12.28%.

Photo taken from the Opening Gap Signals tool inside Benzinga Pro.

Why Is ALT Moving?

Altimmune shares are trading higher after the company agreed to acquire Spitfire Pharma, which will add a NASH drug candidate to the company's portfolio.

Photo taken from the ‘Why Is It Moving?’ Details tool inside Benzinga Pro.

For live updates on ALT, log in or try Benzinga Pro today.


Related Articles (ALT)

View Comments and Join the Discussion!

Posted-In: News Pre-Market Outlook

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at